Home > Back to Publisher > Report Information

OTC Healthcare in Switzerland to 2011

Datamonitor
August 11, 2008
187 Pages - SKU: DFMN1872784

Abstract Table of Contents Search inside this report Related Reports

Countries covered: Switzerland

Introduction

This databook is a detailed information resource covering all the key data points on OTC Healthcare in Switzerland. It includes comprehensive value volume segmentation and market share data. The databook supplies actual data to 2006 and full forecasts to 2011.

Scope

Contains information on:Analgesics,Cough & cold,Indigestion,Medicated skin products,Traditional medicines,Vitamins & Other OTC healthcare products
Provides market value, volume, expenditure and consumption data by market, segment and subsegment
Includes company and brand share data by categories

Highlights

The market for OTC Healthcare in Switzerland decreased between 2001-2006, at an average annual rate of -0.5%.

The leading company in the market in 2006 was Pfizer Inc. The second-largest player was Novartis AG with GlaxoSmithKline Plc in third place.

Reasons to Purchase

Discover the major quantitative trends affecting the OTC Healthcare markets
Understand consumers' consumption and expenditure patterns
Understand the future direction of the market with reliable historical data and full five year forecasting

Additional Information

Databooks are a detailed information resource covering all the key data points across all industry verticals. They provide data covering a particular market at country or regional level in comprehensive tabular and brief contextual format. The databook allows the user to study and analyze the data. This databook is comprised of an overview chapter covering the market as a whole, a chapter examining each category within the market, and a chapter containing socioeconomic analysis and data. It also includes a chapter detailing Datamonitor’s research methodology, and an appendix containing additional details.

Chapter 1 EXECUTIVE SUMMARY
: Summary Market Level - OTC Healthcare; Summary category level - Analgesics; Summary category level - Cough and Cold Preparations; Summary category level - Traditional Medicines; Summary category level - First Aid Kits; Summary category level - Indigestion Preparations; Summary category level - Vitamins and Minerals; Summary category level - Plasters & Bandages; Summary category level - Medicated Skin Products; Summary category level - Other OTC Healthcare Products; Summary category level - Topical OTC Medicines
Chapter 2 INTRODUCTION
: What is this report about?; How to use this report; Market Definition
Chapter 3 MARKET OVERVIEW
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 4 LEADING COMPANY PROFILES
: Pfizer Inc; Novartis AG
Chapter 5 CATEGORY ANALYSIS - ANALGESICS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 6 CATEGORY ANALYSIS - COUGH AND COLD PREPARATIONS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 7 CATEGORY ANALYSIS - TRADITIONAL MEDICINES
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 8 CATEGORY ANALYSIS - FIRST AID KITS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 9 CATEGORY ANALYSIS - INDIGESTION PREPARATIONS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 10 CATEGORY ANALYSIS - VITAMINS AND MINERALS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 11 CATEGORY ANALYSIS - PLASTERS & BANDAGES
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 12 CATEGORY ANALYSIS - MEDICATED SKIN PRODUCTS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 13 CATEGORY ANALYSIS - OTHER OTC HEALTHCARE PRODUCTS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 14 CATEGORY ANALYSIS - TOPICAL OTC MEDICINES
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 15 COUNTRY COMPARISON
: Value; Market Share
Chapter 16 NEW PRODUCT DEVELOPMENT
: Product launches over time; Recent product launches
Chapter 17 SWITZERLAND SOCIOECONOMIC PROFILE
: Country Overview; Key Facts; Political Overview; Switzerland Economic Overview
Chapter 18 SWITZERLAND MACROECONOMIC PROFILE
: Macroeconomic Indicators
Chapter 19 RESEARCH METHODOLOGY
: Methodology overview; Secondary research; Market modelling; Primary research; Data finalisation; Ongoing research
Chapter 20 APPENDIX
: Future readings; How to contact experts in your industry
LIST OF FIGURES
: Figure 1: Switzerland OTC Healthcare value & value forecast, 2001-2011 (CHF m, nominal prices); Figure 2: Switzerland OTC Healthcare category growth comparison, by value, 2001-2011; Figure 3: Switzerland OTC Healthcare company share, by value, 2005-2006 (%); Figure 4: Switzerland Analgesics value & value forecast, 2001-2011 (CHF m, nominal prices); Figure 5: Switzerland Analgesics category growth comparison, by value, 2001-2011; Figure 6: Switzerland Analgesics company share, by value, 2005-2006 (%); Figure 7: Switzerland Cough and Cold Preparations value & value forecast, 2001-2011 (CHF m, nominal prices); Figure 8: Switzerland Cough and Cold Preparations category growth comparison, by value, 2001-2011; Figure 9: Switzerland Cough and Cold Preparations company share, by value, 2005-2006 (%); Figure 10: Switzerland Traditional Medicines value & value forecast, 2001-2011 (CHF m, nominal prices); Figure 11: Switzerland Traditional Medicines company share, by value, 2005-2006 (%); Figure 12: Switzerland First Aid Kits value & value forecast, 2001-2011 (CHF m, nominal prices); Figure 13: Switzerland First Aid Kits company share, by value, 2005-2006 (%); Figure 14: Switzerland Indigestion Preparations value & value forecast, 2001-2011 (CHF m, nominal prices); Figure 15: Switzerland Indigestion Preparations category growth comparison, by value, 2001-2011; Figure 16: Switzerland Indigestion Preparations company share, by value, 2005-2006 (%); Figure 17: Switzerland Vitamins and Minerals value & value forecast, 2001-2011 (CHF m, nominal prices); Figure 18: Switzerland Vitamins and Minerals category growth comparison, by value, 2001-2011; Figure 19: Switzerland Vitamins and Minerals company share, by value, 2005-2006 (%); Figure 20: Switzerland Plasters & Bandages value & value forecast, 2001-2011 (CHF m, nominal prices); Figure 21: Switzerland Plasters & Bandages category growth comparison, by value, 2001-2011; Figure 22: Switzerland Plasters & Bandages company share, by value, 2005-2006 (%); Figure 23: Switzerland Medicated Skin Products value & value forecast, 2001-2011 (CHF m, nominal prices); Figure 24: Switzerland Medicated Skin Products category growth comparison, by value, 2001-2011; Figure 25: Switzerland Medicated Skin Products company share, by value, 2005-2006 (%); Figure 26: Switzerland Other OTC Healthcare Products value & value forecast, 2001-2011 (CHF m, nominal prices); Figure 27: Switzerland Other OTC Healthcare Products category growth comparison, by value, 2001-2011; Figure 28: Switzerland Other OTC Healthcare Products company share, by value, 2005-2006 (%); Figure 29: Switzerland Topical OTC Medicines value & value forecast, 2001-2011 (CHF m, nominal prices); Figure 30: Switzerland Topical OTC Medicines category growth comparison, by value, 2001-2011; Figure 31: Global OTC Healthcare market split (value terms, 2006) - Top 5 countries; Figure 32: Global OTC Healthcare market value, 2001 - 2006 (Top 5 countries); Figure 33: Map of Switzerland; Figure 34: Annual data review process
LIST OF TABLES
: Table 1: OTC Healthcare category definitions; Table 2: Switzerland OTC Healthcare value, 2001-2006 (CHF m, nominal prices); Table 3: Switzerland OTC Healthcare value forecast, 2006-2011 (CHF m, nominal prices); Table 4: Switzerland OTC Healthcare value, 2001-2006 (US$ m nominal prices); Table 5: Switzerland OTC Healthcare value forecast, 2006-2011 (US$ m nominal prices); Table 6: Switzerland OTC Healthcare brand share, by value, 2005-2006 (%); Table 7: Switzerland OTC Healthcare value, by brand 2005-2006 (CHF m nominal prices); Table 8: Switzerland OTC Healthcare company share by value, 2005-2006 (%); Table 9: Switzerland OTC Healthcare value, by company, 2005-2006 (CHF m nominal prices); Table 10: Switzerland OTC Healthcare expenditure per capita, 2001-2006 (CHF, nominal prices); Table 11: Switzerland OTC Healthcare forecast expenditure per capita, 2006-2011 (CHF, nominal prices); Table 12: Switzerland OTC Healthcare expenditure per capita, 2001-2006 (US$ nominal prices); Table 13: Switzerland OTC Healthcare forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 14: Pfizer Inc Key Facts; Table 15: Novartis AG Key Facts; Table 16: Switzerland Analgesics value, 2001-2006 (CHF m, nominal prices); Table 17: Switzerland Analgesics value forecast, 2006-2011 (CHF m, nominal prices); Table 18: Switzerland Analgesics value, 2001-2006 (US$ m nominal prices); Table 19: Switzerland Analgesics value forecast, 2006-2011 (US$ m nominal prices); Table 20: Switzerland Analgesics brand share, by value, 2005-2006 (%); Table 21: Switzerland Analgesics value, by brand 2005-2006 (CHF m nominal prices); Table 22: Switzerland Analgesics company share by value, 2005-2006 (%); Table 23: Switzerland Analgesics value, by company, 2005-2006 (CHF m nominal prices); Table 24: Switzerland Analgesics expenditure per capita, 2001-2006 (CHF, nominal prices); Table 25: Switzerland Analgesics forecast expenditure per capita, 2006-2011 (CHF, nominal prices); Table 26: Switzerland Analgesics expenditure per capita, 2001-2006 (US$ nominal prices); Table 27: Switzerland Analgesics forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 28: Switzerland Cough and Cold Preparations value, 2001-2006 (CHF m, nominal prices); Table 29: Switzerland Cough and Cold Preparations value forecast, 2006-2011 (CHF m, nominal prices); Table 30: Switzerland Cough and Cold Preparations value, 2001-2006 (US$ m nominal prices); Table 31: Switzerland Cough and Cold Preparations value forecast, 2006-2011 (US$ m nominal prices); Table 32: Switzerland Cough and Cold Preparations brand share, by value, 2005-2006 (%); Table 33: Switzerland Cough and Cold Preparations value, by brand 2005-2006 (CHF m nominal prices); Table 34: Switzerland Cough and Cold Preparations company share by value, 2005-2006 (%); Table 35: Switzerland Cough and Cold Preparations value, by company, 2005-2006 (CHF m nominal prices); Table 36: Switzerland Cough and Cold Preparations expenditure per capita, 2001-2006 (CHF, nominal prices); Table 37: Switzerland Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (CHF, nominal prices); Table 38: Switzerland Cough and Cold Preparations expenditure per capita, 2001-2006 (US$ nominal prices); Table 39: Switzerland Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 40: Switzerland Traditional Medicines value, 2001-2006 (CHF m, nominal prices); Table 41: Switzerland Traditional Medicines value forecast, 2006-2011 (CHF m, nominal prices); Table 42: Switzerland Traditional Medicines value, 2001-2006 (US$ m nominal prices); Table 43: Switzerland Traditional Medicines value forecast, 2006-2011 (US$ m nominal prices); Table 44: Switzerland Traditional Medicines brand share, by value, 2005-2006 (%); Table 45: Switzerland Traditional Medicines value, by brand 2005-2006 (CHF m nominal prices); Table 46: Switzerland Traditional Medicines company share by value, 2005-2006 (%); Table 47: Switzerland Traditional Medicines value, by company, 2005-2006 (CHF m nominal prices); Table 48: Switzerland Traditional Medicines expenditure per capita, 2001-2006 (CHF, nominal prices); Table 49: Switzerland Traditional Medicines forecast expenditure per capita, 2006-2011 (CHF, nominal prices); Table 50: Switzerland Traditional Medicines expenditure per capita, 2001-2006 (US$ nominal prices); Table 51: Switzerland Traditional Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 52: Switzerland First Aid Kits value, 2001-2006 (CHF m, nominal prices); Table 53: Switzerland First Aid Kits value forecast, 2006-2011 (CHF m, nominal prices); Table 54: Switzerland First Aid Kits value, 2001-2006 (US$ m nominal prices); Table 55: Switzerland First Aid Kits value forecast, 2006-2011 (US$ m nominal prices); Table 56: Switzerland First Aid Kits brand share, by value, 2005-2006 (%); Table 57: Switzerland First Aid Kits value, by brand 2005-2006 (CHF m nominal prices); Table 58: Switzerland First Aid Kits company share by value, 2005-2006 (%); Table 59: Switzerland First Aid Kits value, by company, 2005-2006 (CHF m nominal prices); Table 60: Switzerland First Aid Kits expenditure per capita, 2001-2006 (CHF, nominal prices); Table 61: Switzerland First Aid Kits forecast expenditure per capita, 2006-2011 (CHF, nominal prices); Table 62: Switzerland First Aid Kits expenditure per capita, 2001-2006 (US$ nominal prices); Table 63: Switzerland First Aid Kits forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 64: Switzerland Indigestion Preparations value, 2001-2006 (CHF m, nominal prices); Table 65: Switzerland Indigestion Preparations value forecast, 2006-2011 (CHF m, nominal prices); Table 66: Switzerland Indigestion Preparations value, 2001-2006 (US$ m nominal prices); Table 67: Switzerland Indigestion Preparations value forecast, 2006-2011 (US$ m nominal prices); Table 68: Switzerland Indigestion Preparations brand share, by value, 2005-2006 (%); Table 69: Switzerland Indigestion Preparations value, by brand 2005-2006 (CHF m nominal prices); Table 70: Switzerland Indigestion Preparations company share by value, 2005-2006 (%); Table 71: Switzerland Indigestion Preparations value, by company, 2005-2006 (CHF m nominal prices); Table 72: Switzerland Indigestion Preparations expenditure per capita, 2001-2006 (CHF, nominal prices); Table 73: Switzerland Indigestion Preparations forecast expenditure per capita, 2006-2011 (CHF, nominal prices); Table 74: Switzerland Indigestion Preparations expenditure per capita, 2001-2006 (US$ nominal prices); Table 75: Switzerland Indigestion Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 76: Switzerland Vitamins and Minerals value, 2001-2006 (CHF m, nominal prices); Table 77: Switzerland Vitamins and Minerals value forecast, 2006-2011 (CHF m, nominal prices); Table 78: Switzerland Vitamins and Minerals value, 2001-2006 (US$ m nominal prices); Table 79: Switzerland Vitamins and Minerals value forecast, 2006-2011 (US$ m nominal prices); Table 80: Switzerland Vitamins and Minerals brand share, by value, 2005-2006 (%); Table 81: Switzerland Vitamins and Minerals value, by brand 2005-2006 (CHF m nominal prices); Table 82: Switzerland Vitamins and Minerals company share by value, 2005-2006 (%); Table 83: Switzerland Vitamins and Minerals value, by company, 2005-2006 (CHF m nominal prices); Table 84: Switzerland Vitamins and Minerals expenditure per capita, 2001-2006 (CHF, nominal prices); Table 85: Switzerland Vitamins and Minerals forecast expenditure per capita, 2006-2011 (CHF, nominal prices); Table 86: Switzerland Vitamins and Minerals expenditure per capita, 2001-2006 (US$ nominal prices); Table 87: Switzerland Vitamins and Minerals forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 88: Switzerland Plasters & Bandages value, 2001-2006 (CHF m, nominal prices); Table 89: Switzerland Plasters & Bandages value forecast, 2006-2011 (CHF m, nominal prices); Table 90: Switzerland Plasters & Bandages value, 2001-2006 (US$ m nominal prices); Table 91: Switzerland Plasters & Bandages value forecast, 2006-2011 (US$ m nominal prices); Table 92: Switzerland Plasters & Bandages brand share, by value, 2005-2006 (%); Table 93: Switzerland Plasters & Bandages value, by brand 2005-2006 (CHF m nominal prices); Table 94: Switzerland Plasters & Bandages company share by value, 2005-2006 (%); Table 95: Switzerland Plasters & Bandages value, by company, 2005-2006 (CHF m nominal prices); Table 96: Switzerland Plasters & Bandages expenditure per capita, 2001-2006 (CHF, nominal prices); Table 97: Switzerland Plasters & Bandages forecast expenditure per capita, 2006-2011 (CHF, nominal prices); Table 98: Switzerland Plasters & Bandages expenditure per capita, 2001-2006 (US$ nominal prices); Table 99: Switzerland Plasters & Bandages forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 100: Switzerland Medicated Skin Products value, 2001-2006 (CHF m, nominal prices); Table 101: Switzerland Medicated Skin Products value forecast, 2006-2011 (CHF m, nominal prices); Table 102: Switzerland Medicated Skin Products value, 2001-2006 (US$ m nominal prices); Table 103: Switzerland Medicated Skin Products value forecast, 2006-2011 (US$ m nominal prices); Table 104: Switzerland Medicated Skin Products brand share, by value, 2005-2006 (%); Table 105: Switzerland Medicated Skin Products value, by brand 2005-2006 (CHF m nominal prices); Table 106: Switzerland Medicated Skin Products company share by value, 2005-2006 (%); Table 107: Switzerland Medicated Skin Products value, by company, 2005-2006 (CHF m nominal prices); Table 108: Switzerland Medicated Skin Products expenditure per capita, 2001-2006 (CHF, nominal prices); Table 109: Switzerland Medicated Skin Products forecast expenditure per capita, 2006-2011 (CHF, nominal prices); Table 110: Switzerland Medicated Skin Products expenditure per capita, 2001-2006 (US$ nominal prices); Table 111: Switzerland Medicated Skin Products forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 112: Switzerland Other OTC Healthcare Products value, 2001-2006 (CHF m, nominal prices); Table 113: Switzerland Other OTC Healthcare Products value forecast, 2006-2011 (CHF m, nominal prices); Table 114: Switzerland Other OTC Healthcare Products value, 2001-2006 (US$ m nominal prices); Table 115: Switzerland Other OTC Healthcare Products value forecast, 2006-2011 (US$ m nominal prices); Table 116: Switzerland Other OTC Healthcare Products brand share, by value, 2005-2006 (%); Table 117: Switzerland Other OTC Healthcare Products value, by brand 2005-2006 (CHF m nominal prices); Table 118: Switzerland Other OTC Healthcare Products company share by value, 2005-2006 (%); Table 119: Switzerland Other OTC Healthcare Products value, by company, 2005-2006 (CHF m nominal prices); Table 120: Switzerland Other OTC Healthcare Products expenditure per capita, 2001-2006 (CHF, nominal prices); Table 121: Switzerland Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (CHF, nominal prices); Table 122: Switzerland Other OTC Healthcare Products expenditure per capita, 2001-2006 (US$ nominal prices); Table 123: Switzerland Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 124: Switzerland Topical OTC Medicines value, 2001-2006 (CHF m, nominal prices); Table 125: Switzerland Topical OTC Medicines value forecast, 2006-2011 (CHF m, nominal prices); Table 126: Switzerland Topical OTC Medicines value, 2001-2006 (US$ m nominal prices); Table 127: Switzerland Topical OTC Medicines value forecast, 2006-2011 (US$ m nominal prices); Table 128: Switzerland Topical OTC Medicines brand share, by value, 2005-2006 (%); Table 129: Switzerland Topical OTC Medicines value, by brand 2005-2006 (CHF m nominal prices); Table 130: Switzerland Topical OTC Medicines company share by value, 2005-2006 (%); Table 131: Switzerland Topical OTC Medicines value, by company, 2005-2006 (CHF m nominal prices); Table 132: Switzerland Topical OTC Medicines expenditure per capita, 2001-2006 (CHF, nominal prices); Table 133: Switzerland Topical OTC Medicines forecast expenditure per capita, 2006-2011 (CHF, nominal prices); Table 134: Switzerland Topical OTC Medicines expenditure per capita, 2001-2006 (US$ nominal prices); Table 135: Switzerland Topical OTC Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 136: Global OTC Healthcare market value, 2006; Table 137: Global OTC Healthcare market split (value terms (US$ m), 2006) - Top 5 countries; Table 138: Leading players - Top 5 countries; Table 139: Switzerland OTC Healthcare new product launches (reports) and SKUs, by company (Top 5 companies), 2006; Table 140: Switzerland OTC Healthcare new product launches (reports), by flavor and fragrances (Top 10 flavors), 2006; Table 141: Switzerland OTC Healthcare new product launches (reports), by Ingredients (Top 10 Ingredients), 2006; Table 142: Switzerland OTC Healthcare new product launches (reports), by Package tags or Claims (Top 10 claims), 2006; Table 143: Switzerland OTC Healthcare new product launches (reports) - Recent 5 launches; Table 144: Switzerland Key Facts; Table 145: Switzerland population, by age group, 2000-2005 (millions); Table 146: Switzerland population forecast, by age group, 2005-2010 (millions); Table 147: Switzerland population, by gender, 2000-2005 (millions); Table 148: Switzerland population forecast, by gender, 2005-2010 (millions); Table 149: Switzerland real GDP, 2000-2005 (CHF bn, 2005 prices); Table 150: Switzerland real GDP forecast, 2005-2010 (CHF bn, 2005 prices); Table 151: Switzerland nominal GDP, 2000-2005 (CHF bn, nominal prices); Table 152: Switzerland real GDP, 2000-2005 (US$ bn, 2005 prices); Table 153: Switzerland real GDP forecast, 2005-2010 (US$ bn, 2005 prices); Table 154: Switzerland consumer price index, 2000-2005 (2000=100); Table 155: Switzerland consumer price index, 2005-2010 (2000=100); Table 156: Switzerland exchange rate, 2000-2005

More Switzerland Over-the-Counter Drugs Reports

OTC Pharmaceuticals in Switzerland by MarketLine
Introduction OTC Pharmaceuticals in Switzerland industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2006-10, and forecast to ...

Incontinence in Switzerland by Euromonitor International
Whereas in 2005 the percentage of the population aged 65 and over was 16%, it grew to 17% in 2010, and it is expected to ...

NRT Smoking Cessation Aids in Switzerland by Euromonitor International
Sales of NRT smoking cessation aids reached CHF17 million in 2010, up 6% in current terms on the previous year. A national smoking ban forbidding ...

Medicated Skin Care in Switzerland by Euromonitor International
A wide variety of very different product types are included in the medicated skin care category, ranging from cosmetic medications such acne and hair loss ...

Herbal/Traditional Products in Switzerland by Euromonitor International
Herbal/traditional medicines are very much in trend in Switzerland. Herbal and natural products are seen as safe and healthy options. Herbal/traditional products are popular in ...

See all reports like this >>

More Switzerland Reports

D&B Country RiskLine Report: Switzerland by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country Report: Switzerland by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Switzerland: Country Profile by MarketLine
INTRODUCTION This report provides a detailed analysis on Switzerland, providing an overview of its political, economic and business environment, represented both textually and in graph and ...

The 2005 Switzerland Economic and Product Market Databook by Icon Group International, Inc.
Market Potential Estimation Methodology Overview This study covers the outlook products in Switzerland. For the year reported, estimates are given for the latent demand, or ...

The Economic Competitiveness of Switzerland: Financials Returns, Labor Productivity and International Gaps by Icon Group International, Inc.
Is Switzerland competitive? With the globalization of markets, the increased mobility of corporate assets, and the need for productive human resources, this question has ...

See all reports like this >>

OTC Healthcare in Switzerland to 2011

Share this report

Other tasks

Research Assistance

Related Markets

Over-the-Counter Drugs Reports

Free Alert Me service